These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 22885422

  • 1. High frequency of calcinosis in juvenile dermatomyositis: a risk factor study.
    Clemente G, Piotto DG, Barbosa C, Peracchi OA, Len CA, Hilário MO, Terreri MT.
    Rev Bras Reumatol; 2012 Aug; 52(4):549-53. PubMed ID: 22885422
    [Abstract] [Full Text] [Related]

  • 2. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, MacNeil I, Momy JA, Avery G, Feldman BM.
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [Abstract] [Full Text] [Related]

  • 3. Vasculitis and calcinosis in juvenile dermatomyositis.
    Truckenbrodt H, Häfner R.
    Acta Univ Carol Med (Praha); 1991 Mar; 37(1-2):8-15. PubMed ID: 1845413
    [Abstract] [Full Text] [Related]

  • 4. [Multi-center analysis of calcinosis in children with juvenile dermatomyositis].
    Miyamae T, Mori M, Inamo Y, Kohno Y, Takei S, Maeda M, Murata T, Nakata S, Kawai H, Hirano Y, Date Y, Kitamura K, Yokota S.
    Ryumachi; 2003 Jun; 43(3):538-43. PubMed ID: 12910962
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis.
    Marhaug G, Shah V, Shroff R, Varsani H, Wedderburn LR, Pilkington CA, Brogan PA.
    Rheumatology (Oxford); 2008 Jul; 47(7):1031-7. PubMed ID: 18448482
    [Abstract] [Full Text] [Related]

  • 6. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK, Yang YH, Wang LC, Chiang BL.
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [Abstract] [Full Text] [Related]

  • 7. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
    Sanner H, Gran JT, Sjaastad I, Flatø B.
    Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
    [Abstract] [Full Text] [Related]

  • 8. [Clinical characteristics of juvenile dermatomyositis].
    Constantin T, Ponyi A, Garami M, Gergely L, Fekete G, Dankó K.
    Orv Hetil; 2003 Jun 22; 144(25):1245-50. PubMed ID: 12901181
    [Abstract] [Full Text] [Related]

  • 9. [Calcinosis of childhood dermatomyositis. Apropos of 10 cases].
    Bruguier A, Texier P, Sluzewski W, Ponsot G, Arthuis M.
    Helv Paediatr Acta; 1984 Mar 22; 39(1):47-54. PubMed ID: 6724996
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
    Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA.
    Rheumatology (Oxford); 2008 Jun 22; 47(6):877-80. PubMed ID: 18403404
    [Abstract] [Full Text] [Related]

  • 12. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.
    Balin SJ, Wetter DA, Andersen LK, Davis MD.
    Arch Dermatol; 2012 Apr 22; 148(4):455-62. PubMed ID: 22184719
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.
    Mathiesen P, Hegaard H, Herlin T, Zak M, Pedersen FK, Nielsen S.
    Scand J Rheumatol; 2012 Feb 22; 41(1):50-8. PubMed ID: 22044089
    [Abstract] [Full Text] [Related]

  • 14. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.
    Saini I, Kalaivani M, Kabra SK.
    Rheumatol Int; 2016 Jul 22; 36(7):961-5. PubMed ID: 27007612
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.
    Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, Maillard S, Oliveira SK, Sztajnbok F, Cuttica R, Beltramelli M, Corona F, Katsicas MM, Russo R, Ferriani V, Burgos-Vargas R, Magni-Manzoni S, Solis-Valleoj E, Bandeira M, Zulian F, Baca V, Cortis E, Falcini F, Alessio M, Alpigiani MG, Gerloni V, Saad-Magalhaes C, Podda R, Silva CA, Lepore L, Felici E, Rossi F, Sala E, Martini A.
    Arthritis Care Res (Hoboken); 2010 Jan 15; 62(1):63-72. PubMed ID: 20191492
    [Abstract] [Full Text] [Related]

  • 16. Early Abnormal Nailfold Capillary Changes Are Predictive of Calcinosis Development in Juvenile Dermatomyositis.
    Nozawa T, Bell-Peter A, Marcuz JA, Whitney K, Vinik O, Shupak R, Dover S, Feldman BM.
    J Rheumatol; 2022 Nov 15; 49(11):1250-1255. PubMed ID: 35914785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment.
    Mukamel M, Horev G, Mimouni M.
    J Pediatr; 2001 May 15; 138(5):763-6. PubMed ID: 11343059
    [Abstract] [Full Text] [Related]

  • 19. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
    Wang A, Morgan GA, Paller AS, Pachman LM.
    J Am Acad Dermatol; 2021 Jun 15; 84(6):1610-1618. PubMed ID: 33359787
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.